Cerebrospinal fluid β-glucuronidase activities in patients with central nervous system metastases

Allen, 1964, β-Glucuronidase activities in cerebrospinal fluid, Arch Neurol, 11, 144, 10.1001/archneur.1964.00460200040004 Shuttleworth, 1968, Early differentiation of chronic meningitis by enzyme assay, Neurology, 18, 534, 10.1212/WNL.18.6.534 Shuttleworth, 1980, CSF β-glucuronidase assay in the diagnosis of neoplastic meningitis, Arch Neurol, 37, 684, 10.1001/archneur.1980.00500600032003 Schold, 1980, Cerebrospinal fluid biochemical markers of central nervous system metastases, Ann Neurol, 8, 597, 10.1002/ana.410080609 Fishman, 1974, β-Glucuronidase, Vol. 2, 929 1972, Empfehlungen der Deutschen Gesellschaft für Klinische Chemie, 10, 182 Griner, 1981, Selection and interpretation of diagnostic tests and procedures, Ann Intern Med, 94, 553 Naus, 1980, The use of patient data for the calculation of reference values for some haematological parameters, J Clin Chem Clin Biochem, 18, 621 Anlyan, 1952, β-Glucuronidase activity of spinal and ventricular fluids in humans, Cancer, 5, 578, 10.1002/1097-0142(195205)5:3<578::AID-CNCR2820050318>3.0.CO;2-9 Fishman, 1948, Application of an improved glucuronidase assay method to the study of human blood β-glucuronidase, J Biol Chem, 173, 449, 10.1016/S0021-9258(18)57416-0 Talalay, 1946, Chromogenic substrates. II. Phenolphthalein glucuronic acid as a substrate for assay of glucuronidase activity, J Biol Chem, 166, 757, 10.1016/S0021-9258(17)35214-6 Zweig, 1982, Why we need better test evaluations, Clin Chem, 28, 1272, 10.1093/clinchem/28.6.1272 Wasserstrom, 1982, Diagnosis and treatment of leptomeningeal metastases from solid tumours, Cancer, 49, 759, 10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7 Ongerboer de Visser, 1983, Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma, Neurology, 33, 1565, 10.1212/WNL.33.12.1565